Search clinical trials for: ALECSAT

Total 8 results

CytoVac A/S

Completed

Safety Study of Repeated Dosing of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy (ALECSAT)

Hormone-refractory Prostate Cancer

Denmark
CytoVac A/S

Completed

A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients (ALECSAT-GBM)

Glioblastoma Multiforme

Denmark
CytoVac A/S

Completed

Safety Study of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy (ALECSAT)

Hormone-refractory Prostate Cancer

Denmark
CytoVac A/S

Completed

A Prospective, Open Phase I Study to Investigate the Tolerability and Efficacy of ALECSAT to Pancreas Cancer Patients

Pancreatic Cancer

Denmark
Henrik Ditzel
National Board of Health, Denmark; CytoVac A/S

Recruiting

ImmunoBreast - A Phase Ib Study

Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer

Denmark
CytoVac A/S

Terminated

Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan

Glioblastoma Multiforme

Denmark
CytoVac A/S

Completed

Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma (ALECSAT)

Glioblastoma

Sweden
Sheba Medical Center
Cell science systems

Completed

Alcat Based Elimination Diet for the Treatment of Irritable Bowel Syndrome; a Randomized Double Blind Sham Control Trial

IBS - Irritable Bowel Syndrome

Israel

3

Subscribe